UK Watchdog Starts Investigation Into AstraZeneca's Acquisition of Alexion
May 25 2021 - 2:41AM
Dow Jones News
By Ian Walker
The U.K. Competition and Markets Authority said Tuesday that it
is considering whether AstraZeneca PLC's acquisition of Alexion
Pharmaceuticals Inc. will lessen competition within the U.K., and
is inviting comments from interested parties ahead of a final
decision.
The regulator said interested parties have until June 3 to offer
their comments. It has also set a deadline of July 21 for a Phase 1
decision into the deal.
AstraZeneca on Dec. 12 agreed to buy Boston-based Alexion
Pharmaceuticals for $39 billion in cash and stock, a move that
would bolster the British drug company's footprint in immunology
and rare diseases.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
May 25, 2021 02:28 ET (06:28 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
